Danyelza (naxitamab)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Danyelza (naxitamab), covering 2025-07-14 to 2025-07-14. Get the full timeline:
Most recent: Clinical Trial Update: Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma [Phase 1]